Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Press Release
Article
Camber Launches Prucalopride Tablets
Key Takeaways
- Camber Pharmaceuticals introduces Prucalopride Tablets, a generic for Motegrity®, targeting chronic idiopathic constipation in adults.
- Chronic idiopathic constipation affects 10-17% of the global population, predominantly women and older adults.
Camber Pharmaceuticals, a leader in generic drug approvals and launches, is proud to add Prucalopride Tablets [proo-KAL-oh-pride] to its growing portfolio. Prucalopride Tablets are generic for Motegrity®.
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation (CIC) in adults. CIC affects about 10-17% of the global population and is more commonly seen in women and older adults.
Prucalopride Tablets are available in 1 mg and 2 mg strengths in 30 count bottles.
To learn more about Prucalopride Tablets, please visit: www.camberpharma.com/prucalopride
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Videos
Related Content
